Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03000998 · ClinicalTrials.gov registry record · NA

Web App Technology for Boys and Parents: Improving HPV Vaccine Uptake

A NA study, sponsored by Klein Buendel.

Completed
Registry status
NA
Development phase
432
Enrollment target

NCT03000998 is a NA study that has completed, run by Klein Buendel. The registered enrollment target is 432 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03000998, a NA study, has completed, sponsored by Klein Buendel.

COMPLETED
Registry status
NA
Development phase
432 participants
Enrollment target

Study Summary

The uptake of vaccines for Human Papillomavirus (HPV) in the U.S. is far below recommended levels, particularly for adolescent boys and especially among minority families. Proposed here is a mobile web application ("mobile web app") for personal computers, smart phones, and tablet computers that will accurately inform parents and adolescent boys about the HPV vaccination and address unique concerns about its safety and effectiveness for boys. The BoyVac mobile web app will be evaluated for its ability to improve vaccine outcomes in a randomized efficacy trial with parents and adolescent boys aged 11-13 years.

Interventions

  • BEHAVIORAL Web App Intervention Group
  • BEHAVIORAL Usual Customary Care Group

Trial Details

FieldValue
Enrollment Target 432 participants
Start Date 2017-01-31
Est. Completion 2022-06-30
Phase NA

Sponsor

Klein Buendel

34 total trials

What the Registry Record Tells You About NCT03000998

The ClinicalTrials.gov registry entry for NCT03000998 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 432 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Klein Buendel, which has 34 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Web App Intervention Group is the first listed.

NCT03000998 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03000998 about?

NCT03000998 is a clinical study titled "Web App Technology for Boys and Parents: Improving HPV Vaccine Uptake". The uptake of vaccines for Human Papillomavirus (HPV) in the U.S. is far below recommended levels, particularly for adolescent boys and especially among minority families. Proposed here is a mobile web application ("mobile web app") for personal computers, smart phones, and tablet computers that wil...

What is the current status of trial NCT03000998?

This trial is currently completed. It is a NA study. The enrollment target is 432 participants. The study started on 2017-01-31. Estimated completion is 2022-06-30.

What interventions are being tested in trial NCT03000998?

The interventions under investigation include: Web App Intervention Group (BEHAVIORAL), Usual Customary Care Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT03000998?

This trial is sponsored by Klein Buendel, which has 34 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.